Provided by Tiger Trade Technology Pte. Ltd.

BiomX Inc.

4.70
+0.470011.11%
Post-market: 4.63-0.0700-1.49%17:57 EST
Volume:112.80K
Turnover:519.09K
Market Cap:7.18M
PE:-0.12
High:4.91
Open:4.40
Low:4.24
Close:4.23
52wk High:22.06
52wk Low:4.10
Shares:1.53M
Float Shares:1.03M
Volume Ratio:1.38
T/O Rate:10.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-38.2088
EPS(LYR):-28.0224
ROE:-154.50%
ROA:-48.05%
PB:-0.88
PE(LYR):-0.17

Loading ...

Company Profile

Company Name:
BiomX Inc.
Exchange:
AMEX
Establishment Date:
2015
Employees:
55
Office Location:
22 Einstein Street,Floor 4,Ness Ziona,Israel
Zip Code:
7414003
Fax:
- -
Introduction:
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

Directors

Name
Position
Jonathan Solomon
Chief Executive Officer and Director
Russell Greig
Chairman
Alan Moses
Director
Edward Williams
Director
Gregory Merril
Director
Jesse Goodman
Director
Jonathan Leff
Director
Susan Blum
Director

Shareholders

Name
Position
Jonathan Solomon
Chief Executive Officer and Director
Marina Wolfson
Chief Financial Officer
Merav Bassan
Chief Development Officer